×
About 3,595 results

ALLMedicine™ Follicle-stimulating Hormone Center

Research & Reviews  1,699 results

Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as par...
https://doi.org/10.1186/s12958-021-00744-x 10.1093/humrep/deu070 10.3389/fendo.2018.00033 10.1016/j.fertnstert.2018.04.037 10.3389/fendo.2019.00429 10.1186/1477-7827-10-9 10.1016/j.fertnstert.2016.10.033 10.1016/j.fertnstert.2012.11.051 10.4274/jtgga.2017.0058 10.1080/09513590.2019.1650345 10.1093/hropen/hoaa009 10.1093/humupd/dmp036 10.1093/humrep/dem204 10.1111/j.1471-0528.2012.03412.x 10.1007/s40268-016-0126-z 10.12688/f1000research.10382.1 10.1093/humrep/dex321 10.1177/1933719111432859 10.1016/S1472-6483(10)60654-2 10.1007/s10815-008-9266-6 10.1016/j.fertnstert.2007.05.055 10.1093/humrep/dew149 10.1016/j.rbmo.2011.04.002 10.2147/PPA.S21421 10.1080/17425247.2017.1237940 10.1080/17425247.2016.1203899 10.1080/17425247.2019.1651290 10.1080/17425247.2017.1289174 10.1080/17425247.2018.1450386 10.1016/j.rbmo.2014.11.013 10.1016/j.rbmo.2011.11.014 10.2147/DDDT.S104104 10.1093/humupd/8.6.559 10.1016/j.fertnstert.2009.02.049 10.1111/j.1471-1842.2009.00848.x 10.1016/j.rbmo.2017.01.012 10.1186/1477-7827-12-6 10.1016/j.fertnstert.2011.12.016 10.1016/j.rbmo.2017.06.019 10.1186/1477-7827-7-111 10.1016/S1472-6483(10)60310-0 10.1016/j.rbmo.2009.10.009 10.1093/humrep/dem317 10.3109/14647270903586356 10.1016/j.rbmo.2015.01.005 10.1186/s12958-015-0135-8 10.1016/S0015-0282(00)00471-4 10.1093/oxfordjournals.humrep.a138053 10.1093/humrep/dem270 10.1093/humrep/deh668 10.1016/S0950-3552(05)80085-9 10.1093/humupd/dmx017 10.1371/journal.pone.0106854 10.1016/j.rbmo.2011.09.017 10.1093/humrep/der251 10.3389/fendo.2019.00281 10.1210/jcem.85.9.6767 10.1016/j.fertnstert.2018.02.128 10.1016/j.fertnstert.2016.08.048 10.3109/09513590.2011.633666 10.1016/S1472-6483(10)61098-X 10.1023/A:1009470602525 10.1093/humrep/dey061 10.1093/humrep/dey062 10.1093/humupd/8.3.291
Reproductive Biology and Endocrinology : RB&E; Fatemi H, Bilger W et. al.

May 12th, 2021 - Individualization of the follicle-stimulating hormone (FSH) starting dose is considered standard clinical practice during controlled ovarian stimulation (COS) in patients undergoing assisted reproductive technology (ART) treatment. Furthermore, th...

The effects of multiple controlled ovarian hyperstimulation over a 2-year period on ova...
https://doi.org/10.21037/apm-21-330
Annals of Palliative Medicine; Bu X, Ma Y et. al.

May 10th, 2021 - To evaluate the effects of controlled ovarian hyperstimulation (COH) on ovarian reserve function during in vitro fertilization and embryo transfer (IVF-ET). From August 2018 to August 2020, the medical records of patients who received IVF-ET in th...

Early-onset climacterium is not associated with impaired vitamin D status: a population...
https://doi.org/10.1097/GME.0000000000001781
Menopause (New York, N.Y.); Lumme JE, Savukoski SM et. al.

May 5th, 2021 - To investigate vitamin D status in women with the onset of the climacteric phase by age 46 as both early menopause and inadequate vitamin D status may increase the risk of adverse health outcomes. A cross-sectional study included 2,544, 46-year-ol...

Response to ovulation induction treatments in women with polycystic ovary syndrome as a...
https://doi.org/10.1007/s10815-021-02217-x
Journal of Assisted Reproduction and Genetics; Vagios S, Sacha CR et. al.

May 2nd, 2021 - To assess whether anti-Müllerian hormone (AMH) can predict response to ovulation induction (OI) with clomiphene citrate (CC), letrozole (LET), or follicle-stimulating hormone (FSH) in women with polycystic ovary syndrome (PCOS) undergoing OI/intra...

The status and comparison of ovarian reserve between fertile and infertile healthy Chin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084010
Medicine Zhou SJ, Sun TC et. al.

Apr 28th, 2021 - We aimed to investigate ovarian reserve status, and explore differences in ovarian reserve between fertile and infertile healthy Chinese women of reproductive age.We recruited 442 fertile women aged 23 to 49 years (mean: 35.22 ± 4.91 years) as sub...

see more →

Drugs  49 results see all →

Clinicaltrials.gov  1,801 results

Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as par...
https://doi.org/10.1186/s12958-021-00744-x 10.1093/humrep/deu070 10.3389/fendo.2018.00033 10.1016/j.fertnstert.2018.04.037 10.3389/fendo.2019.00429 10.1186/1477-7827-10-9 10.1016/j.fertnstert.2016.10.033 10.1016/j.fertnstert.2012.11.051 10.4274/jtgga.2017.0058 10.1080/09513590.2019.1650345 10.1093/hropen/hoaa009 10.1093/humupd/dmp036 10.1093/humrep/dem204 10.1111/j.1471-0528.2012.03412.x 10.1007/s40268-016-0126-z 10.12688/f1000research.10382.1 10.1093/humrep/dex321 10.1177/1933719111432859 10.1016/S1472-6483(10)60654-2 10.1007/s10815-008-9266-6 10.1016/j.fertnstert.2007.05.055 10.1093/humrep/dew149 10.1016/j.rbmo.2011.04.002 10.2147/PPA.S21421 10.1080/17425247.2017.1237940 10.1080/17425247.2016.1203899 10.1080/17425247.2019.1651290 10.1080/17425247.2017.1289174 10.1080/17425247.2018.1450386 10.1016/j.rbmo.2014.11.013 10.1016/j.rbmo.2011.11.014 10.2147/DDDT.S104104 10.1093/humupd/8.6.559 10.1016/j.fertnstert.2009.02.049 10.1111/j.1471-1842.2009.00848.x 10.1016/j.rbmo.2017.01.012 10.1186/1477-7827-12-6 10.1016/j.fertnstert.2011.12.016 10.1016/j.rbmo.2017.06.019 10.1186/1477-7827-7-111 10.1016/S1472-6483(10)60310-0 10.1016/j.rbmo.2009.10.009 10.1093/humrep/dem317 10.3109/14647270903586356 10.1016/j.rbmo.2015.01.005 10.1186/s12958-015-0135-8 10.1016/S0015-0282(00)00471-4 10.1093/oxfordjournals.humrep.a138053 10.1093/humrep/dem270 10.1093/humrep/deh668 10.1016/S0950-3552(05)80085-9 10.1093/humupd/dmx017 10.1371/journal.pone.0106854 10.1016/j.rbmo.2011.09.017 10.1093/humrep/der251 10.3389/fendo.2019.00281 10.1210/jcem.85.9.6767 10.1016/j.fertnstert.2018.02.128 10.1016/j.fertnstert.2016.08.048 10.3109/09513590.2011.633666 10.1016/S1472-6483(10)61098-X 10.1023/A:1009470602525 10.1093/humrep/dey061 10.1093/humrep/dey062 10.1093/humupd/8.3.291
Reproductive Biology and Endocrinology : RB&E; Fatemi H, Bilger W et. al.

May 12th, 2021 - Individualization of the follicle-stimulating hormone (FSH) starting dose is considered standard clinical practice during controlled ovarian stimulation (COS) in patients undergoing assisted reproductive technology (ART) treatment. Furthermore, th...

The effects of multiple controlled ovarian hyperstimulation over a 2-year period on ova...
https://doi.org/10.21037/apm-21-330
Annals of Palliative Medicine; Bu X, Ma Y et. al.

May 10th, 2021 - To evaluate the effects of controlled ovarian hyperstimulation (COH) on ovarian reserve function during in vitro fertilization and embryo transfer (IVF-ET). From August 2018 to August 2020, the medical records of patients who received IVF-ET in th...

Early-onset climacterium is not associated with impaired vitamin D status: a population...
https://doi.org/10.1097/GME.0000000000001781
Menopause (New York, N.Y.); Lumme JE, Savukoski SM et. al.

May 5th, 2021 - To investigate vitamin D status in women with the onset of the climacteric phase by age 46 as both early menopause and inadequate vitamin D status may increase the risk of adverse health outcomes. A cross-sectional study included 2,544, 46-year-ol...

Testosterone - testosterone gel-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78384754-5883-46b1-84e7-c063b4b4be82

May 3rd, 2021 - Testosterone Gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: •Primary hypogonadism (congenital or acquired): testicular failure due to conditions suc...

Response to ovulation induction treatments in women with polycystic ovary syndrome as a...
https://doi.org/10.1007/s10815-021-02217-x
Journal of Assisted Reproduction and Genetics; Vagios S, Sacha CR et. al.

May 2nd, 2021 - To assess whether anti-Müllerian hormone (AMH) can predict response to ovulation induction (OI) with clomiphene citrate (CC), letrozole (LET), or follicle-stimulating hormone (FSH) in women with polycystic ovary syndrome (PCOS) undergoing OI/intra...

see more →

News  43 results

Pregnancy After Pioneering Treatment for Early Menopause
https://www.medscape.com/viewarticle/949091

Apr 11th, 2021 - A novel therapy combining platelet-rich plasma (PRP) with follicle-stimulating hormone (FSH) that is injected directly into the ovaries has the potential to restore ovarian function for women who experience early menopause, possibly allowing for p...

How ovarian reserve testing can (and cannot) address your patients’ fertility concerns
https://www.mdedge.com/obgyn/article/178569/obstetrics/how-ovarian-reserve-testing-can-and-cannot-address-your-patients/page/0/1

Oct 31st, 2018 - #1 What tests are part of an ovarian reserve assessment? What is their utility? FSH and estradiol Follicle-stimulating hormone (FSH) and estradiol should be checked together in the early follicular phase (days 2 to 4 of the cycle). Elevated levels.

An Update on Premenstrual Disorders: Diagnosis and Management
https://www.staging.medscape.com/viewarticle/895944

May 6th, 2018 - Hormones and the Menstrual Cycle The menstrual cycle is accompanied by characteristic hormonal changes.[1] As the activity of the corpus luteum declines, the pituitary release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) incr...

An Update on Premenstrual Disorders: Diagnosis and Management
https://www.medscape.com/viewarticle/895944

May 6th, 2018 - Hormones and the Menstrual Cycle The menstrual cycle is accompanied by characteristic hormonal changes.[1] As the activity of the corpus luteum declines, the pituitary release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) incr...

Biomarkers of Ovarian Reserve Not Linked to Fertility
https://www.staging.medscape.com/viewarticle/886807

Oct 9th, 2017 - Biomarkers used to estimate ovarian reserve were not associated with fertility among women aged 30 to 44 years with no history of infertility who had tried to conceive for 3 months or less, a prospective study has found. "These findings do not sup...

see more →

Patient Education  3 results see all →